Latest Als News

Page 6 of 44
Antimony Resources has begun trading under the ANT code as its Tecomatlán processing plant in Mexico moves closer to its first processing campaign. About 200 tonnes of mineralised material has been prepared, but assay results and commissioning outcomes are still to come.
Maxwell Dee
Maxwell Dee
21 Sept 2026
Killi Resources has intersected a 50-metre zone of visually estimated crystalline magnetite 600 metres south of Lodestone’s existing 110Mt inferred resource. The result also identified a separate 16-metre hanging-wall zone, but assays and metallurgical testing are still pending.
Maxwell Dee
Maxwell Dee
21 Sept 2026
Bayan Mining and Minerals has begun a third phase of surface sampling at its Bayan Springs South gold project in Nevada, extending an open southern anomaly and testing a previously unsampled northern fault intersection. The work is intended to sharpen drill targets, while assays from the company’s completed Desert Star RC program are expected in October 2026.
Maxwell Dee
Maxwell Dee
21 Sept 2026
Viking Mines has identified several wide zones of visually confirmed scheelite in ongoing RC drilling at its Linka tungsten project in Nevada, including 22 metres across a 24-metre horizon. The encouraging visual results remain unassayed, leaving laboratory results as the next critical test of grade and continuity.
Maxwell Dee
Maxwell Dee
17 Sept 2026
Minrex Resources has completed its 33-hole Barje infill program and begun a 6,604-metre greenfield campaign at Tlamino in Serbia. The drilling will test whether Barje and Liska form part of a single mineralised system extending more than 1.5 kilometres.
Maxwell Dee
Maxwell Dee
16 Sept 2026
Kaili Resources has reported a peak one-metre assay of 1,125.51 ppm total rare earth oxides from shallow aircore drilling at its Coodalya tenement in South Australia. The result adds to an emerging zone of elevated values, but the early-stage program has not yet established continuity, scale or economic significance.
Maxwell Dee
Maxwell Dee
15 Sept 2026
Neurizon will redeem 1 million convertible notes held by Obsidian for US$1.15 million, while securing a two-month standstill on share sales. The biotechnology company says the transaction leaves it funded through the HEALEY ALS trial readout and completion.
Ada Torres
Ada Torres
10 Sept 2026
A multimillion-dollar, multiyear NIH grant will fund an expanded access program for Neurizon’s investigational NUZ-001, potentially giving up to 200 US patients access to the therapy for as long as 96 weeks. The program is designed to add long-term safety, survival and biomarker data alongside the pivotal HEALEY ALS trial.
Ada Torres
Ada Torres
9 Sept 2026
ActivEX has identified preliminary rare earth element anomalies across an 8km soil grid at its Aramac Project in Queensland, including 28 samples above 1,000ppm TREE. The readings come from handheld pXRF analysis and must be confirmed by laboratory assays now pending from ALS.
Maxwell Dee
Maxwell Dee
8 Sept 2026
Neurizon has appointed Dr Chris Bremer as chief executive as its NUZ-001 ALS program moves towards topline Phase 2/3 results expected in late Q2 2027. The incoming CEO brings more than 20 years of pharmaceutical and biotechnology experience, including over US$1 billion in licensing transactions.
Ada Torres
Ada Torres
7 Sept 2026
Hawsons Iron has confirmed its ability to upgrade magnetite concentrate to a premium 69.3% iron grade through bulk-scale elutriation testwork, significantly reducing impurities and enhancing potential revenue streams.
Maxwell Dee
Maxwell Dee
4 Sept 2026
Eclipse Metals' latest testwork confirms that up to 94% of neodymium and praseodymium are locked in identifiable REE minerals at Grønnedal, underpinning a promising beneficiation strategy ahead of flotation trials.
Maxwell Dee
Maxwell Dee
3 Sept 2026

Browse the archive

Full archive